Skip to main content

[]

Intended for healthcare professionals
Skip to main content
Open access
Research article
First published online January 30, 2024

Neuropsychological assessment in MS is outdated and is in need for innovation: Yes

Up to 65% of people with multiple sclerosis (PwMS) experience cognitive symptoms such as slower information processing and memory deficits.1 These can develop already early in the disease, and negatively impact daily functioning, work ability, and overall quality of life.13 To evaluate cognitive performance and detect cognitive dysfunction, neuropsychological assessment (NPA) is used. This typically consists of paper-and-pencil tests that find their roots several decades ago.4 That brings us to our primary question: is the currently used NPA old-fashioned and in need for innovation?
There are several challenges with NPAs that are currently used for PwMS (e.g. Brief International Cognitive Assessment for MS;5 Minimal Assessment of Cognitive Function in Multiple Sclerosis6). First, they require the involvement of specialized personnel (and subsequently money due to higher health care costs), hindering frequent and structural assessment of cognitive functioning and thus early identification of cognitive decline.2 Second, the long duration of these assessments can be particularly burdensome for PwMS who experience fatigue and/or mood problems, such that test scores for this group may not reflect true cognitive abilities. A third, more practical limitation of current NPAs in MS is that they are often unsuitable for annual retest assessments, due to learning effects and limited number of parallel versions. This is especially problematic for the California Verbal Learning Test–second edition, frequently used to assess verbal memory in PwMS, as learning effects are generally strong for this domain and only two parallel versions exist.7 Given the observed increase in overall performance on memory tests over time (in line with the Flynn-effect, i.e. increase in IQ scores), the interpretation of follow-up test scores may be unreliable.8 This may lead to an overestimation of cognitive functioning, which would be especially concerning for PwMS with subtle cognitive impairments. Fourth, norm scores are often outdated originating from a period in which Internet was unavailable and society functioned in a different way. As such, norms are in dire need for updating. Finally, NPA outcomes only marginally inform us about daily functioning and the lack of ecological validity is a sincere concern.4
Many of the challenges described above can be overcome by digitalizing NPA. For instance, the administration of a test battery and automated scoring without involvement of a test leader would not only facilitate regular cognitive screening in MS, but it would also avoid human error in its scoring.9 However, as digitalizing NPA is basically taking the old-fashioned test and putting on a new jacket, one can argue that within the field of neuropsychology we need to (and can) do better than that.
There has been relatively little progress in the field of neuropsychology (especially when compared to the rapid advances in other fields of MS, such as ongoing developments in neuroimaging technology to monitor disease activity). This may be a result of the hard work and dedication put into developing, validating, and standardizing tests, having professionals relying on their well-known instruments. However, technological advancements can bring NPA for PwMS (and beyond) to the next level once new test paradigms and scoring methods are developed that align with cognitive requirements of today’s society. For instance, computerized assessments allowing for computer adaptive testing (CAT), where the test adapts to the ability level of the patient, will enable more sophisticated assessment, for example, fitting with a person’s work requirements.4 As a nice side-effect, assessments can be more efficient and less burdensome for both PwMS and health care providers. Furthermore, technological solutions that allow for different measurements compared to what we have available today, like easy adjustment of stimuli and test versions, higher standardization, and inclusion of additional metrics (e.g. pencil pressure, the number, length, and position of pauses, consistency over time),4 will make our measures more fine-grained than they currently are—which is exactly what we need!
We need NPAs that embrace the complexity of the disorder. For example, PwMS frequently experience physical symptoms such as fatigue, visual, or motor impairments that can directly affect cognitive performance on NPA. Especially early in the disease, changes in motor functioning may be too subtle to be detected via existing coarse instruments such as the Expanded Disability Status Scale (EDSS), yet they may already impact patients’ responses significantly. Integrating fine-grained measures of visual and motor functioning (e.g. stability of trajectories in terms of directionality, velocity, or pressure) in innovative paradigms, such as virtual reality and eye-tracking, might offer possible solutions. Another promising development in this context is smartphone applications detecting changes in typing behavior, indicating disease activity.10 Overall, a shift toward more comprehensive assessments is crucial to effectively address the challenges posed by MS.
From a more philosophical standpoint, it may be worthwhile to re-examine the overall concept of cognition. The cultural evolution that we have been part of as society may have changed how our brains respond to stimuli from the environment. The modern world is immersed in technology, presenting new cognitive challenges such as processing information at faster speeds and differently utilizing memory and navigational skills. For instance, with the introduction of smartphones, it is no longer necessary to memorize a route and factual information can be looked up within seconds. On the contrary, we are continuously distracted by snippets of information. This may have expanded or at least changed our cognitive abilities dramatically. Therefore, to provide a more accurate assessment of cognitive functioning today, it may be necessary to develop neuropsychological tests based on new theoretical concepts that consider the demands of the modern world.
In summary, while current NPAs provide valuable information about cognitive functioning in PwMS, there is potential for improvement. By embracing digitalization, developing new and more comprehensive tests, and accounting for physical symptoms, we propose that cognitive functioning in PwMS can be assessed more efficiently and reliably. Moreover, updating norm scores and re-considering the concept of cognition appear necessary. Overall, we advocate for innovation in neuropsychological testing to benefit early and accurate identification (and possibly treatment) of cognitive impairment in PwMS.

Declaration of Conflicting Interests

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: P.T.W. has no conflict of interest regarding this publication. M.F.L.R. has no conflict of interest regarding this publication. H.E.H. is an editor of the Multiple Sclerosis Journal controversies sections, who received research support from the Dutch MS Research Foundation and the Dutch Research Council. She has served as a consultant for or received research support from Atara Biotherapeutics, Biogen, Novartis, Celgene/Bristol Meyers Squibb, Sanofi Genzyme, MedDay, and Merck BV.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

References

1. Sumowski JF, Benedict R, Enzinger C, et al. Cognition in multiple sclerosis: State of the field and priorities for the future. Neurology 2018; 90(6): 278–288.
2. Klein OA, Das Nair R, Ablewhite J, et al. Assessment and management of cognitive problems in people with multiple sclerosis: A National Survey of Clinical Practice. Int J Clin Pract 2019; 73(3): e13300.
3. Campbell J, Rashid W, Cercignani M, et al. Cognitive impairment among patients with multiple sclerosis: Associations with employment and quality of life. Postgrad Med J 2017; 93(1097): 143–147.
4. Miller JB, Barr WB. The technology crisis in neuropsychology. Arch Clin Neuropsychol 2017; 32(5): 541–554.
5. Langdon DW, Amato MP, Boringa J, et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler 2012; 18(6): 891–898.
6. Benedict RHB, Cookfair D, Gavett R, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12(4): 549–558.
7. Woods SP, Delis DC, Scott JC, et al. The California Verbal Learning Test – Second edition: Test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms. Arch Clin Neuropsych 2006; 21(5): 413–420.
8. Baxendale S. The Flynn effect and memory function. J Clin Exp Neuropsychol 2010; 32(7): 699–703.
9. Van Dongen L, Westerik B, Van der Hiele K, et al. Introducing Multiple Screener: An unsupervised digital screening tool for cognitive deficits in MS. Mult Scler Relat Disord 2020; 38: 101479.
10. Lam KH, Twose J, McConchie H, et al. Smartphone-derived keystroke dynamics are sensitive to relevant changes in multiple sclerosis. Eur J Neurol 2022; 29(2): 522–534.

Cite article

Cite article

Cite article

OR

Download to reference manager

If you have citation software installed, you can download article citation data to the citation manager of your choice

Share options

Share

Share this article

Share with email
Email Article Link
Share on social media

Share access to this article

Sharing links are not relevant where the article is open access and not available if you do not have a subscription.

For more information view the Sage Journals article sharing page.

Information, rights and permissions

Information

Published In

Article first published online: January 30, 2024
Issue published: February 2024

Rights and permissions

© The Author(s), 2024.
Creative Commons License (CC BY 4.0)
This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
PubMed: 38291552

Authors

Affiliations

Pauline T Waskowiak
MS Center Amsterdam, Department of Medical Psychology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands
Marit FL Ruitenberg
Health, Medical and Neuropsychology Unit, Leiden University, Leiden, The Netherlands
Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands
Hanneke E Hulst
Health, Medical and Neuropsychology Unit, Leiden University, Leiden, The Netherlands
Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands

Notes

PT Waskowiak MS Center Amsterdam, Department of Medical Psychology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, De Boelelaan 1118, 1081 HV Amsterdam, The Netherlands. [email protected]

Metrics and citations

Metrics

Journals metrics

This article was published in Multiple Sclerosis Journal.

View All Journal Metrics

Article usage*

Total views and downloads: 843

*Article usage tracking started in December 2016


Altmetric

See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores



Articles citing this one

Receive email alerts when this article is cited

Web of Science: 0

Crossref: 0

There are no citing articles to show.

Figures and tables

Figures & Media

Tables

View Options

View options

PDF/EPUB

View PDF/EPUB

Access options

If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:


Alternatively, view purchase options below:

Purchase 24 hour online access to view and download content.

Access journal content via a DeepDyve subscription or find out more about this option.